C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2728816
The application relates to methods for determining whether or not antiviral therapies will be effective. In particular, the present application provides a method using miRNA, e.g. miR- 122 or miR-296-5p, for determining the likelihood that a subject having a viral infection of the liver will be responsive to antiviral therapy that includes stimulation of Interferon (IFN) activity, and kits for the performance of said determination.
La présente invention concerne des procédés consistant à déterminer si des thérapies antivirales seront efficaces ou non. En particulier, la présente invention concerne un procédé utilisant l'ARNmi, par exemple le miR-122 ou le miR-296-5p, afin de déterminer la probabilité, pour un sujet ayant une infection virale du foie, de répondre à une thérapie antivirale qui comprend la stimulation de l'activité de l'interféron (IFN), et des kits pour effectuer ladite détermination.
Filipowicz Witold
Heim Markus
Krol Jacek
Markiewicz Ilona
Sarasin-Filipowicz Magdalena
Fetherstonhaugh & Co.
Novartis Forschungsstiftung Zweigniederlassung Friedrich Miesche
University Hospital Basel
LandOfFree
Prediction of antiviral therapy response does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prediction of antiviral therapy response, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prediction of antiviral therapy response will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1779883